TAMI THORNTON: Open Payments
NPI 1841683323 · BLUE SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 46 payments from 16 companies in 2025. Trend: 2023 $576 · 2024 $927 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $173 |
| ABBVIE INC. | 7 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $153 |
| Novo Nordisk Inc | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Viatris Specialty LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| PFIZER INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: MOUNJARO, AIRSUPRA, QULIPTA, REXULTI, Auvelity, JARDIANCE, UBRELVY, Wegovy.
Industry payments across MO — which companies pay providers there.
